Boothbay Fund Management, LLC Puma Biotechnology, Inc. Transaction History

Boothbay Fund Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$2.23 - $4.49 $39,905 - $80,348	17,895 New	17,895 $77,000
Q1 2023 May 15, 2023	BUY	$2.21 - $4.82 $8,864 - $19,333	4,011 Added 19.84%	24,229 $74,000
Q4 2022 Feb 14, 2023	BUY	$2.12 - $5.08 $42,862 - $102,707	20,218 New	20,218 $85,000
Q3 2021 Nov 15, 2021	SELL	$6.63 - $9.39 $82,112 - $116,295	-12,385 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $16,577 - $21,413	1,846 Added 17.52%	12,385 $114,000
Q1 2020 May 15, 2020	SELL	$6.28 - $14.57 $268,470 - $622,867	-42,750 Reduced 80.22%	10,539 $89,000
Q4 2019 Feb 14, 2020	SELL	$6.5 - $10.73 $73,079 - $120,637	-11,243 Reduced 17.42%	53,289 $466,000
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $564,655 - $829,236	64,532 New	64,532 $695,000

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $137M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.